Cargando…
Identification of Cathepsin D as a Plasma Biomarker for Alzheimer’s Disease
Although Alzheimer’s disease (AD) is the most common neurodegenerative disease, there are still no drugs available to treat or prevent AD effectively. Here, we examined changes in levels of selected proteins implicated in the pathogenesis of AD using plasma samples of control subjects and patients w...
Autores principales: | Kim, Jae-Whan, Jung, Soon-Young, Kim, Youngbin, Heo, Hansol, Hong, Chang-Hyung, Seo, Sang-Won, Choi, Seong-Hye, Son, Sang-Joon, Lee, Seongju, Chang, Jaerak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827175/ https://www.ncbi.nlm.nih.gov/pubmed/33445607 http://dx.doi.org/10.3390/cells10010138 |
Ejemplares similares
-
Identification of BAG2 and Cathepsin D as Plasma Biomarkers for Parkinson’s Disease
por: Kang, Juhee, et al.
Publicado: (2020) -
FAM21 directs SNX27–retromer cargoes to the plasma membrane by preventing transport to the Golgi apparatus
por: Lee, Seongju, et al.
Publicado: (2016) -
Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS
por: Roh, Hyun Woong, et al.
Publicado: (2022) -
MITD1 is recruited to midbodies by ESCRT-III and participates in cytokinesis
por: Lee, Seongju, et al.
Publicado: (2012) -
Elevated Expression of Cathepsin K in Periodontal Ligament Fibroblast by Inflammatory Cytokines Accelerates Osteoclastogenesis via Paracrine Mechanism in Periodontal Disease
por: Heo, Soon Chul, et al.
Publicado: (2021)